Marika Nestor

1.6k total citations
62 papers, 1.1k citations indexed

About

Marika Nestor is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Marika Nestor has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 31 papers in Radiology, Nuclear Medicine and Imaging and 26 papers in Molecular Biology. Recurrent topics in Marika Nestor's work include Monoclonal and Polyclonal Antibodies Research (18 papers), Radiopharmaceutical Chemistry and Applications (16 papers) and Glycosylation and Glycoproteins Research (10 papers). Marika Nestor is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (18 papers), Radiopharmaceutical Chemistry and Applications (16 papers) and Glycosylation and Glycoproteins Research (10 papers). Marika Nestor collaborates with scholars based in Sweden, Singapore and United States. Marika Nestor's co-authors include Diana Spiegelberg, Bo Stenerlöw, Bengt Glimelius, Soumi Kundu, Hans Lundqvist, Gamze Kuku, Matti Anniko, Jakob Haglöf, Mikael K.R. Engskog and Vladimir Tolmachev and has published in prestigious journals such as Nature Communications, PLoS ONE and Analytical Chemistry.

In The Last Decade

Marika Nestor

58 papers receiving 1.1k citations

Peers

Countries citing papers authored by Marika Nestor

Since Specialization

Citations

This map shows the geographic impact of Marika Nestor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marika Nestor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marika Nestor more than expected).

Fields of papers citing papers by Marika Nestor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marika Nestor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marika Nestor. The network helps show where Marika Nestor may publish in the future.

Co-authorship network of co-authors of Marika Nestor

This figure shows the co-authorship network connecting the top 25 collaborators of Marika Nestor. A scholar is included among the top collaborators of Marika Nestor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marika Nestor. Marika Nestor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting mutant p53: Evaluation of novel anti-p53R175H monoclonal antibodies as diagnostic tools 2025 ·Scientific Reports ·Diana Spiegelberg, (unknown), (unknown), (unknown), (unknown), (unknown), Ram Kumar Selvaraju, Kanaga Sabapathy, Marika Nestor, David P. Lane	0
2	Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts 2025 ·Molecular Cancer Therapeutics ·(unknown), (unknown), (unknown), Adam Stenman, Ram Kumar Selvaraju, Hans Lundqvist, Camilla Hofström, (unknown), C. Christofer Juhlin, Jan Zedenius, Fredrik Y. Frejd, Marika Nestor	2
3	Affinity maturation and optimization of CD44v6-targeting antibodies for molecular radiotherapy 2025 ·Nuclear Medicine and Biology ·(unknown), Camilla Hofström, Helena Persson, Leif Dahllund, Fredrik Y. Frejd, Marika Nestor	1
4	Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma 2025 ·Blood Advances ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Louella Vasquez, (unknown), (unknown), José I. Martı́n-Subero, Fredrik Öberg, Torbjörn Karlsson, Marika Nestor, Elke De Bruyne, Antonia Kalushkova, Helena Jernberg‐Wiklund	0
5	Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas 2023 ·Heliyon ·(unknown), Juliana Imgenberg‐Kreuz, Diana Spiegelberg, Johan Botling, Marika Nestor	4
6	Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy 2023 ·Scientific Reports ·(unknown), H. Berglund, Lova Segerström, Matthias Walle, Camilla Hofström, Helena Persson, Per‐Åke Nygren, Johan Nilvebrant, Fredrik Y. Frejd, Marika Nestor	3
7	The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth In Vivo and Potentiates Radiotherapy 2022 ·Cancer Research Communications ·(unknown), Diana Spiegelberg, Pavitra Kannan, (unknown), (unknown), Long Jiang, (unknown), (unknown), Dilraj Lama, Francisca Castillo, (unknown), Warren W. Kretzschmar, (unknown), Nicolas Fritz, Eduardo J. Villablanca, Mikael C. I. Karlsson, Fredrik Wermeling, Marika Nestor, David P. Lane, Saikiran K. Sedimbi	8
8	Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo 2021 ·Journal of Controlled Release ·Fernanda Andrade, Diana Rafael, (unknown), Sara Montero‐Herradón, (unknown), Joaquin Seras‐Franzoso, Zamira V. Díaz‐Riascos, (unknown), Natalia García‐Aranda, (unknown), Diego Arango, Marika Nestor, Ibane Abasolo, Bruno Sarmento, Simó Schwartz	47
9	Enhancing the therapeutic effects of in vitro targeted radionuclide therapy of 3D multicellular tumor spheroids using the novel stapled MDM2/X-p53 antagonist PM2 2020 ·EJNMMI Research ·(unknown), (unknown), Christopher J. Brown, David P. Lane, Marika Nestor	6
10	Adduct formation in electrospray ionisation-mass spectrometry with hydrophilic interaction liquid chromatography is strongly affected by the inorganic ion concentration of the samples 2019 ·Journal of Chromatography A ·(unknown), Jakob Haglöf, Mikael K.R. Engskog, Marika Nestor, Mikael Hedeland, Torbjörn Arvidsson, Curt Pettersson	23
11	The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 Tumors 2018 ·Cancer Research ·Diana Spiegelberg, (unknown), (unknown), Christopher J. Brown, David P. Lane, Marika Nestor	31
12	Impact of surfactants on the target recognition of Fab-conjugated PLGA nanoparticles 2018 ·European Journal of Pharmaceutics and Biopharmaceutics ·Patrick J. Kennedy, (unknown), Daniel Ferreira, Marika Nestor, Carla Oliveíra, Pedro L. Granja, Bruno Sarmento	18
13	Novel Real-Time Proximity Assay for Characterizing Multiple Receptor Interactions on Living Cells 2017 ·Analytical Chemistry ·(unknown), Hanna Björkelund, Marika Nestor, Karl Andersson, Jos Buijs	6
14	Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model 2015 ·European Journal of Nuclear Medicine and Molecular Imaging ·Diana Spiegelberg, (unknown), Ram Kumar Selvaraju, Olof Eriksson, Bo Stenerlöw, Marika Nestor	22
15	In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study 2014 ·EJNMMI Research ·(unknown), Diana Spiegelberg, Johan Nilvebrant, (unknown), Marika Nestor	17
16	Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells 2014 ·PLoS ONE ·(unknown), Diana Spiegelberg, Bengt Glimelius, Bo Stenerlöw, Marika Nestor	170
17	Choice of labeling and cell line influences interactions between the Fab fragment AbD15179 and its target antigen CD44v6 2013 ·Nuclear Medicine and Biology ·(unknown), Diana Spiegelberg, (unknown), Marika Nestor	16
18	Targeted therapy in head and neck cancer 2012 ·Tumor Biology ·Soumi Kundu, Marika Nestor	62
19	Improved Tumor-to-Organ Ratios of a Novel ⁶⁷ Ga-Human Epidermal Growth Factor Radionuclide Conjugate with Preadministered Antiepidermal Growth Factor Receptor Affibody Molecules 2011 ·Cancer Biotherapy and Radiopharmaceuticals ·(unknown), (unknown), Irina Velikyan, Diana Spiegelberg, (unknown), Vladimir Tolmachev, Hans Lundqvist, Marika Nestor	5
20	Tumor-Cell Targeted Epidermal Growth Factor Liposomes Loaded with Boronated Acridine: Uptake and Processing 2003 ·Pharmaceutical Research ·Erika Bohl Kullberg, Marika Nestor, Lars Gedda	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact